Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients

Blood Pressure

Volumn 20, Issue 4, 2011, Pages 244-251

  Muiesan, Maria Lorenza ^a   Salvetti, Massimo ^a   Belotti, Eugenia ^a   Paini, Anna ^a   Rosei, Claudia Agabiti ^a   Aggiusti, Carlo ^a   Scotti, Aurelio ^b   De Ciuceis, Carolina ^a   Rizzoni, Damiano ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Italfarmaco SpA   (Italy)

Author keywords

Barnidipine; Essential hypertension; Flow mediated vasodilation; Hydrochlorothiazide

Indexed keywords

CREATININE; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEPIRODIPINE; POTASSIUM; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FLOW MEDIATED VASODILATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HEMATOCRIT; HUMAN; HYPERTENSION; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VASODILATATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BRACHIAL ARTERY; CALCIUM CHANNEL BLOCKERS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; VASODILATION;

EID: 79960786373     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2011.561072     Document Type: Article

References (30)

1. Brunner H, Cockcroft JR, Deanfi eld J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233-246. (Pubitemid 40279622)
2. Deanfi eld JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115:1285-1295. (Pubitemid 46594773)
3. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation. 2005;111:363-368. (Pubitemid 40165345)
4. Muiesan ML, Salvetti M, Paini A, Monteduro C, Galbassini G, Poisa P, et al. Prognostic role of fl ow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens. 2008; 26:1612-1618.
5. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: Clinical implications. Drugs. 2002;62:265-284. (Pubitemid 34169434)
6. Deanfi eld J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7-17. (Pubitemid 40128972)
7. Malhotra HS, Plosker GL. Barnidipine. Drugs. 2001;61: 989-996. (Pubitemid 32575398)
8. Motomura S, Hashimoto K. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: Comparison of cardiovascular profi le of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (- )-(S)-(S) conformation, with those of nifedipine and nicardipine. Jpn J Pharmacol. 1990;52:319-330. (Pubitemid 20070275)
9. Argenziano L, Izzo R, Iovino G, De Luca N, Parrella L, Morisco C, Trimarco B. Distinct vasodilation, without refl ex neurohormonal activation, induced by barnidipine in hypertensive patients. Blood Press Suppl. 1998;1:9-14. (Pubitemid 28281288)
10. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J. 1995;74:247-253.
11. O 'B rien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697-701. (Pubitemid 40523262)
12. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
13. Gemignani V, Faita F, Ghiadoni L, Poggianti E, Demi M. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging. 2007;26:393-404. (Pubitemid 46392347)
14. Muiesan ML. Nifedipine GITS, but not hydrochrolothiazide, improves fl ow-dependent vasodilation of brachial artery in essential hypertensive patients. Am J Hypertens. 1999;12:40A.
15. Muiesan ML, Salvetti M, Monteduro C, Rizzoni D, Zulli R, Corbellini C, et al. Effect of treatment on fl ow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension. 1999;33(1 Pt 2):575-580. (Pubitemid 29065723)
16. Mizuno Y, Jacob RF, Mason RP. Effects of calcium channel and renin - angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease. Am J Hypertens. 2008;21:1076-1085.
17. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens. 2002;15(2 Pt 1):105-110. (Pubitemid 34161083)
18. Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997;30:1606-1612. (Pubitemid 27528112)
19. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA. Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens. 2004;17:743-748. (Pubitemid 39201087)
20. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, et al. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension. 2001;37:943-948. (Pubitemid 32221618)
21. Wassmann S, Hilgers S, Laufs U, Bohm M, Nickenig G. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia- associated endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2002;22:1208-1212. (Pubitemid 34764875)
22. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive e patients treated with a beta-blockeror a calcium channel antagonist. J Hypertens. 1996;14: 1247-1255. (Pubitemid 26343505)
23. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, et al. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 1995;26:118-123.
24. Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens. 2008;26:494-500. (Pubitemid 351317258)
25. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. Curr Hypertens Rep. 2000;2:64-70.
26. Ghiadoni, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003;41:1281-1286. (Pubitemid 36706078)
27. Spirou A, Rizos E, Liberopoulos EN, Kolaitis N, Achimastos A, Tselepis AD, et al. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: A pilot study. J Cardiovasc Pharmacol Ther. 2006;11:256-261. (Pubitemid 44936239)
28. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21(6 Pt 2):929-933. (Pubitemid 23166942)
29. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109(23 Suppl 1):III15 - III19. (Pubitemid 38786438)
30. Brook RD. Mechanism of differential effects of antihypertensive agents on serum lipids. Curr Hypertens Rep. 2000;2: 370-377.